Long‐term remission and survival in dogs with high‐grade, B cell lymphoma treated with chemotherapy with or without sequential low‐dose rate half‐body irradiation
Abstract Background Standard of care for dogs with high‐grade lymphoma, multiagent chemotherapy, achieves good initial responses but long‐term remissions are infrequent; previous studies using half‐body irradiation suggest improved long‐term outcomes. Hypothesis The addition of low‐dose rate half‐bo...
Main Authors: | Matthew P. Best, Rod C. Straw, Elias Gumpel, Darren R. Fry |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-11-01
|
Series: | Journal of Veterinary Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1111/jvim.16840 |
Similar Items
-
Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma
by: Jacob M. Siewert, et al.
Published: (2023-11-01) -
Large T‐cell extradural lymphoma with concurrent marked cerebrospinal fluid eosinophilia in a dog
by: Anna M. Massie, et al.
Published: (2023-11-01) -
Prognosis and complete remission rate of diffuse large B‐cell lymphoma patients in standard R‐CHOP with reduction of vincristine: A retrospective study
by: Fatemeh Riasi, et al.
Published: (2023-12-01) -
A randomized controlled trial to assess safety and efficacy between terminal chop, stop and chop, and direct chop
by: Aprajita Sinha, et al.
Published: (2023-01-01) -
Comparison of “Nagahara Phaco-Chop” and “Stop-And-Chop Phacoemulsification Techniques”
by: Devrim Toslak, et al.
Published: (2018-07-01)